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Abstract
Subclavian artery stenosis (SAS) resulting in coronary subclavian steal syndrome (CSSS) is a common but under recognized
pathology following coronary artery bypass surgery (CABG). Patients with SAS may be asymptomatic due to the sub-clinical
diversion of blood ﬂow from the myocardium and retrograde blood ﬂow during catheter angiography in the left internal
mammary artery (LIMA) may be the ﬁrst suggestion of CSSS. The management of SAS, causing CSSS, may rarely require
acute assessment and intervention. However, full anatomical assessment of the stenosis morphology may be limited on
ﬂuoroscopy. Correction of SAS may be essential to achieve effective reperfusion therapy.
INTRODUCTION
Coronary subclavian steal syndrome (CSSS) is an uncommon
complication following cardiac bypass surgery involving the
left internal mammary artery (LIMA) [1]. Subclavian artery sten-
osis (SAS) proximal to the LIMA graft can result in retrograde
blood ﬂow and diminished myocardial perfusion. It is therefore
important to suspect CSSS as a rare but important potential
cause of chest pain and myocardial ischaemia in patients fol-
lowing coronary artery bypass graft (CABG) surgery.
SAS affects ~2% of the general population with an increased
prevalence in patients with concomitant cardiovascular disease
[2, 3]. Despite SAS being relatively common in patients with
previous cardiac surgery, patients are rarely investigated for
CSSS on re-presentation with cardiac chest pain. We report an
unusual case of a patient who was asymptomatic following
CABG until presentation with acute coronary syndrome.
Emergency reperfusion by recanalization of an acutely
occluded aorto-coronary graft was compounded by acute sub-
clavian steal that negatively impacted on myocardial perfusion
until correction of SAS.
CASE REPORT
A 68-year-old male presented with abrupt central chest pain on
waking with diaphoresis in the early hours of the morning. The
pain did not radiate and was not relieved by glyceryl trinitrate
spray. He denied any other symptoms. There were no upper or
lower limb extremity symptoms (i.e. peripheral claudication,
muscle fatigue, weakness, numbness) or cerebrovascular symp-
toms (i.e. syncope, headache, visual disturbances). At the time of
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presentation, the patient had a past medical history of CABG
surgery performed in 2002 for unstable angina. The LIMA was
anastomosed to the diagonal artery, and three autologous long
saphenous vein grafts to the: left anterior descending (LAD),
right coronary artery (RCA) and obtuse marginal artery (OMA).
Percutaneous coronary stenting of the vein graft to the proximal
obtuse marginal was later performed successfully in 2011 for an
acute coronary syndrome. Post-intervention, there was no sten-
osis evident in the LIMA graft or vein grafts to the RCA and
OMA. However, 75% stenosis was evident in the vein graft to the
LAD. Despite this, he had been free of cardiac symptoms until
this acute presentation. Previous medical history included
hypertension and hypercholesterolaemia. There was no history
of carotid or peripheral vascular disease, and there was no evi-
dence to suggest diabetes mellitus. Regular medications
included aspirin, ramipril, bisoprolol and simvastatin. There was
also no family history of cardiovascular disease. The patient was
a smoker who consumed four cigarettes per day (0.2 pack-year).
At the time of clinical examination the patient was pain free
with a National Early Warning Score of 0 and clinically euvole-
mic [4]. Chest examination was unremarkable. Heart sounds
were normal with no audible murmurs. He had a regular pulse
(91 bpm) with no radial-radial delay. Blood pressure was mea-
sured at 117/85mmHg, however, individual arm measurements
were not recorded. There was no evidence of increase jugular
venous pressure or peripheral oedema. Blood tests highlighted
an elevated troponin I measured at 50 000 ng/L (normal labora-
tory limit <50 ng/L). An electrocardiogram performed demon-
strated hyperacute ST-segment elevation in the anterior leads.
In light of these ﬁndings, the patient was moved immedi-
ately to the cardiac catheterization laboratory for emergency
percutaneous coronary intervention (PCI). Angiography of the
coronary arteries identiﬁed a co-dominant circulation. There
was complete acute occlusion of the vein graft to the LAD with
visible thrombus. In addition, a severe stenosis of the proximal
section of the vein graft to the RCA, the stent within the vein
graft to the OMA appeared patent. Retrograde blood ﬂow was
observed within the LIMA graft following revascularization of
the LAD (Fig. 1). Angiographic imaging of the aortic arch was
subsequently undertaken and stenosis of the proximal sub-
clavian artery was identiﬁed (Fig. 2a). CSSS physiology was
clearly evident.
Successful PCI with thrombectomy and implantation of
three drug eluting stents was performed to the occluded vein
graft to the LAD. This resulted in satisfactory blood ﬂow down
the graft but ongoing diminished ﬂow into the native LAD with
blood ﬂow away from the heart via the patent LIMA. Ongoing
chest pain and continued ST-elevation was present suggestive
of unsatisfactory myocardial reperfusion despite patent con-
duits, an acute CSSS was therefore suspected. Urgent review
was sought with the on-call vascular interventional radiologist
to determine optimal treatment for the SAS. A 8mm × 20mm
Cobalt Assurant stent was deployed at the origin of the left sub-
clavian artery (Fig. 2b). This resulted in relief of the acute CSSS
with immediate antegrade blood ﬂow down both grafts and
into the native vessels beyond the surgical anastomoses
(Fig. 2c). Relief of chest pain and improvement in ECG changes
was subsequently noted. No immediate intervention was per-
formed on the vein graft to the RCA.
Two days later the patient was discharged pain free. He was
prescribed a year long course of dual antiplatelet therapy and
secondary prevention medications were optimized with the
conversion of simvastatin to high dose atorvastatin.
DISCUSSION
LIMA bypass graft during CABG surgery is a surgical standard
[5, 6]. It was originally thought that CSSS is a relatively uncom-
mon phenomenon following CABG, with a reported incidence
of between 0.2 and 6.8%, it is now thought that this is an
under-estimate of the true clinical magnitude of the problem
[2, 7]. On angiography, we demonstrate the typical transit of
blood through the coronary circulation observed with CSSS
[8, 9]. In our case, the presence of an apparently asymptomatic
SAS resulted in complicated and delayed myocardial reperfu-
sion, due to poor ﬂow down the LIMA graft, despite successful
graft PCI until treatment of the SAS.
SAS is a common pathology with a prevalence of between 3
and 4% in the general population. It is often secondary to extrin-
sic compression, arteritis, inﬂammation due to radiation and
rarely ﬁbromuscular dysplasia [3]. Furthermore, SAS is associated
with concomitant coronary artery disease (CAD), peripheral vas-
cular disease and carotid artery disease. It can cause signiﬁcant
morbidity due to ischaemia of the upper extremities and in cer-
tain situations the myocardium as demonstrated in our case.
Patients may typically report upper extremity symptoms such as
arm claudication or muscle fatigue, and rarely rest pain and ﬁn-
ger necrosis [3]. Furthermore, patients may report neurological
symptoms consistent with vertebrobasilar hypoperfusion, due to
the competitive diversion of blood ﬂow to the subclavian artery
through a patent circle of Willis [3]. However, these features may
not be always present as demonstrated by our case.
Despite up to 50% of patients with CAD having SAS, it is not
routinely investigated in patients representing with cardiac
ischaemia following CABG. Patients with SAS are typically inves-
tigated by vascular surgeons, following clinical examination and
measurement of the blood pressure between arms, with either
duplex ultra-sonography, computer tomography angiography
(CTA) or magnetic resonance angiography (MRA) [10]. This
allows for patient to be adequately counselled after timely dis-
cussion regarding risk and beneﬁts of potential intervention.
In the emergency setting, such as PCI for acute ST-elevation
MI, where SAS with CSSS is incidentally identiﬁed, it may not
be always possible to evaluate the optimal method of interven-
tion on ﬂuoroscopy. However, recognition of these typical
angiographic features should drive immediate decision on
treatment, since uncorrected CSSS will attenuate the beneﬁcial
effect of emergency revascularisation. Angiogram features that
raise suspicion of SAS include the inability to catheterize the
left subclavian artery and retrograde ﬂow in the LIMA graft.
Figure 1: Angiograms (LAO 30°, cranial 0°) illustrating (in white): vein graft, left
anterior descending artery (LAD), diagonal artery (Diag) and left internal mam-
mary artery (LIMA). Red arrows demonstrate antegrade ﬂow down vein graft
and retrograde ﬂow up the LIMA.
Coronary subclavian steal syndrome | 435
D
ow
nloaded from
 https://academ
ic.oup.com
/om
cr/article-abstract/2018/12/om
y102/5194302 by Edw
ard Boyle Library user on 14 D
ecem
ber 2018
Although endovascular intervention is associated with a 93%
technical and clinical success, there is a 1% risk of stroke and
stent patency is 89% at 5 years [3]. It is important to note that
not all cases of SAS may be suitable for endovascular stenting
due to anatomy suitability or plaque morphology. There is an
inherent risk that a heavily calciﬁed stenotic lesion, which can-
not be adequately assessed on ﬂuoroscopy, may result in com-
plications when acutely treated [11]. In our case we judged the
risk of ongoing myocardial ischaemia/infarction due to CSSS
physiology as high and therefore this mandated immediate
treatment of the SAS.
Several case studies have reported the identiﬁcation of CSSS
whilst performing acute coronary intervention [8, 12]. The
measurement the blood pressure from both arms is a simple
assessment tool in diagnosing SAS that is often overlooked.
The is a growing body of evidence suggesting the a difference
in the systolic blood pressure of >10mmHg between arms is
predictive of SAS [13, 14]. However, at present, there is no con-
sensus which imaging modality is best to assess for SAS in an
elective setting. Non-invasive imaging that may be useful
include doppler ultrasound, MRA or CTA. Doppler ultrasound
has the advantage of being relatively cheap with minimal radi-
ation exposure. It may demonstrate: low ﬂow or a damped
waveform in the left subclavian artery, retrograde ﬂow in the
left vertebral artery or if the proximal end of LIMA is visualized
retrograde ﬂow. MRA or CTA of the arch/left subclavian may
conﬁrm and outline anatomy of the lesion and may be valuable
in planning intervention. These modalities could be used to
evaluate the location and degree of stenosis of the subclavian
artery and help determine the likelihood of the SAS being the
culprit lesion for any myocardial ischaemia [15]. Furthermore,
high-risk patients such as patients exposed to prior radiation
therapy to the chest or, a past medical history of vasculitis, per-
ipheral vascular disease or carotid artery disease may poten-
tially have the greatest beneﬁt.
CONCLUSIONS
Our case highlights that in an emergency setting the correction of
SAS causing CSSS may be essential to achieve effective reperfu-
sion therapy. Key angiographic features may aid diagnosis but in
an elective setting there is currently no consensus on the best
pre-intervention management strategy. The treatment in many
cases is relatively straightforward with the aid of an interventional
radiologist. We demonstrate that on occasions it may be vital for
the interventional cardiologist to look away from the heart.
SUPPLEMENTARY MATERIAL
Supplementary material is available at Oxford Medical Case
Reports online.
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